Obetrol

A historical pharmaceutical product used for weight loss and ADHD

Overview

Obetrol was a pharmaceutical product that was originally marketed for the treatment of obesity and later for attention deficit hyperactivity disorder (ADHD). It was a combination of several amphetamine salts and was first introduced in the 1950s.

Composition

Obetrol contained a mixture of amphetamine and dextroamphetamine salts. These are central nervous system stimulants that affect chemicals in the brain and nerves that contribute to hyperactivity and impulse control.

Medical Uses

Obesity

Obetrol was initially prescribed as an appetite suppressant to aid in weight loss for patients with obesity. The amphetamine salts in Obetrol work by increasing the release of norepinephrine and dopamine in the brain, which helps to reduce appetite and increase energy expenditure.

ADHD

Later, Obetrol was used in the treatment of attention deficit hyperactivity disorder (ADHD). The medication helps increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.

History

Obetrol was first introduced in the 1950s by Obetrol Pharmaceuticals. It gained popularity in the 1960s and 1970s as a weight loss drug. However, due to concerns about the potential for substance abuse and addiction, its use became more restricted.

In the 1990s, the rights to Obetrol were acquired by Richwood Pharmaceuticals, which reformulated the drug and rebranded it as Adderall. Adderall is now widely used for the treatment of ADHD and narcolepsy.

Side Effects

Common side effects of Obetrol included insomnia, dry mouth, increased heart rate, and anxiety. Due to its stimulant properties, there was also a risk of dependence and abuse.

Regulation

Obetrol, like other amphetamine-based medications, was classified as a Schedule II controlled substance in the United States, indicating a high potential for abuse and dependence.

Gallery

Obetrol tablets

Related pages

• Adderall
• Amphetamine
• Attention deficit hyperactivity disorder
• Obesity